FDA reports new deaths with diabetes drug Byetta
(AP)
AP - Federal regulators are working on a stronger label for a widely used diabetes drug marketed by Amylin Pharmaceuticals Inc. and Eli Lilly & Co. after deaths continue to be reported despite earlier government warnings.

Read more...